Johnson & Johnson’s Sales Slide 11% During the Pandemic
Declines in medical devices and beauty products led the way

J&J's pharmaceutical unit proved resilient even during the pandemic.
Getty Images

Johnson & Johnson’s worldwide year-over-year sales declined 10.8% in the second quarter of 2020, as fewer consumers had elective surgery or opted to buy beauty products during the pandemic.